Wooree Bio Co.,Ltd

KOSDAQ:A082850 Stock Report

Market Cap: ₩149.2b

Wooree BioLtd Balance Sheet Health

Financial Health criteria checks 6/6

Wooree BioLtd has a total shareholder equity of ₩268.2B and total debt of ₩93.3B, which brings its debt-to-equity ratio to 34.8%. Its total assets and total liabilities are ₩659.5B and ₩391.3B respectively. Wooree BioLtd's EBIT is ₩30.4B making its interest coverage ratio 22.3. It has cash and short-term investments of ₩166.0B.

Key information

34.8%

Debt to equity ratio

₩93.27b

Debt

Interest coverage ratio22.3x
Cash₩166.02b
Equity₩268.17b
Total liabilities₩391.34b
Total assets₩659.51b

Recent financial health updates

Recent updates

Risks Still Elevated At These Prices As Wooree Bio Co.,Ltd (KOSDAQ:082850) Shares Dive 28%

Oct 23
Risks Still Elevated At These Prices As Wooree Bio Co.,Ltd (KOSDAQ:082850) Shares Dive 28%

Risks Still Elevated At These Prices As Wooree Bio Co.,Ltd (KOSDAQ:082850) Shares Dive 27%

Sep 07
Risks Still Elevated At These Prices As Wooree Bio Co.,Ltd (KOSDAQ:082850) Shares Dive 27%

Wooree BioLtd (KOSDAQ:082850) Hasn't Managed To Accelerate Its Returns

Aug 30
Wooree BioLtd (KOSDAQ:082850) Hasn't Managed To Accelerate Its Returns

Is Wooree BioLtd (KOSDAQ:082850) A Risky Investment?

Aug 10
Is Wooree BioLtd (KOSDAQ:082850) A Risky Investment?

Wooree Bio Co.,Ltd's (KOSDAQ:082850) Shares Climb 37% But Its Business Is Yet to Catch Up

Jul 19
Wooree Bio Co.,Ltd's (KOSDAQ:082850) Shares Climb 37% But Its Business Is Yet to Catch Up

Wooree BioLtd's (KOSDAQ:082850) Earnings Seem To Be Promising

May 25
Wooree BioLtd's (KOSDAQ:082850) Earnings Seem To Be Promising

These 4 Measures Indicate That Wooree BioLtd (KOSDAQ:082850) Is Using Debt Reasonably Well

May 03
These 4 Measures Indicate That Wooree BioLtd (KOSDAQ:082850) Is Using Debt Reasonably Well

Wooree Bio Co.,Ltd's (KOSDAQ:082850) Share Price Boosted 50% But Its Business Prospects Need A Lift Too

Apr 26
Wooree Bio Co.,Ltd's (KOSDAQ:082850) Share Price Boosted 50% But Its Business Prospects Need A Lift Too

Should You Invest In Wooree BioLtd (KOSDAQ:082850)?

Feb 28
Should You Invest In Wooree BioLtd (KOSDAQ:082850)?

Here's Why Wooree BioLtd (KOSDAQ:082850) Can Manage Its Debt Responsibly

Feb 01
Here's Why Wooree BioLtd (KOSDAQ:082850) Can Manage Its Debt Responsibly

Is Wooree Bio Co.,Ltd's (KOSDAQ:082850) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

Jan 12
Is Wooree Bio Co.,Ltd's (KOSDAQ:082850) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

Wooree BioLtd (KOSDAQ:082850) Shareholders Have Enjoyed A Whopping 478% Share Price Gain

Dec 21
Wooree BioLtd (KOSDAQ:082850) Shareholders Have Enjoyed A Whopping 478% Share Price Gain

Here's Why We Think Wooree BioLtd's (KOSDAQ:082850) Statutory Earnings Might Be Conservative

Nov 29
Here's Why We Think Wooree BioLtd's (KOSDAQ:082850) Statutory Earnings Might Be Conservative

Financial Position Analysis

Short Term Liabilities: A082850's short term assets (₩530.7B) exceed its short term liabilities (₩350.2B).

Long Term Liabilities: A082850's short term assets (₩530.7B) exceed its long term liabilities (₩41.2B).


Debt to Equity History and Analysis

Debt Level: A082850 has more cash than its total debt.

Reducing Debt: A082850's debt to equity ratio has reduced from 90.4% to 34.8% over the past 5 years.

Debt Coverage: A082850's debt is well covered by operating cash flow (47.4%).

Interest Coverage: A082850's interest payments on its debt are well covered by EBIT (22.3x coverage).


Balance Sheet


Discover healthy companies